Cancer Immunotherapy News and Research

RSS
Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Research findings show effective way to harness anti-tumor potential of macrophages in cancer therapy

Research findings show effective way to harness anti-tumor potential of macrophages in cancer therapy

Scientists devise novel DNA vaccine approach against important cancer antigen targets

Scientists devise novel DNA vaccine approach against important cancer antigen targets

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Glowing mice could mark major step forward for new gene therapy

Glowing mice could mark major step forward for new gene therapy

European researchers highlight potential of xenografts in cancer research and treatment

European researchers highlight potential of xenografts in cancer research and treatment

Researchers suggest new approach to slow cancer growth using tumor-derived dendritic cells

Researchers suggest new approach to slow cancer growth using tumor-derived dendritic cells

Research offers new clues to prolong lifespan of the body's disease-fighting NK cells

Research offers new clues to prolong lifespan of the body's disease-fighting NK cells

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

New research suggests novel combination approach to fight against gliomas

New research suggests novel combination approach to fight against gliomas

Study suggests new options for improving cancer immunotherapy

Study suggests new options for improving cancer immunotherapy

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Experimental T-cell therapy shows promise in preventing AML relapse

Experimental T-cell therapy shows promise in preventing AML relapse

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

New approach could overcome large immunosuppressive tumors

New approach could overcome large immunosuppressive tumors

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

Mount Sinai awarded $10 million grant to explore cellular, molecular mechanisms of GVHD

Mount Sinai awarded $10 million grant to explore cellular, molecular mechanisms of GVHD

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.